Related topics: Patient safety, Consolidation, Clinical evolution, Clinical Development, Phase I-II, Phase III-IV, Regulatory affairs
US clinical trial review groups Independent Review Consulting (IRC) and Ethical Review Committee (ERC) are to merge and operate under the name Ethical and Independent Review Services (E&I).
While both organizations have considerable experience in overseeing large clinical development programmes, the merger combines IRC’s focus on federally-funded studies and device trials with ERC’s expertise in multi-centre assessments.
Under the terms of the proposed merger, the two organizations will begin implementing an integration plan immediately while they continue to operate as their respective organizations.
Further details of the plan and its proposed time lines have not been disclosed.
Copyright - Unless otherwise stated all contents of this web site are © 2012 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions